Gary M. Winer - 16 May 2025 Form 4 Insider Report for HCW Biologics Inc. (HCWB)

Reporting relationship: Director
Issuer ticker: HCWB
Reported as of: 16 May 2025
Net transaction value: +$9,998
SEC form: 4
Accepted by SEC: 20 May 2025, 16:35:07 UTC
Prior SEC filing: 09 May 2025
Next SEC filing: 28 May 2025
Source filing: View source filing
Reporting owner signature: /s/ Nicole Valdivieso, as Attorney-in-Fact for Gary M. Winer

Key filing fact

Gary M. Winer filed Form 4 for HCW Biologics Inc. (HCWB) on 20 May 2025.

Key facts

This page summarizes Gary M. Winer's Form 4 filing for HCW Biologics Inc. (HCWB).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 20 May 2025, 16:35.

Change

Previous filing in this sequence was filed on 09 May 2025.
Current net transaction value: +$9,998.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001822095 Primary reporting owner

Winer Gary M

Relationship: Director
Address: C/O HCW BIOLOGICS INC, 2929 N. COMMERCE PARKWAY, MIRAMAR
Signature: /s/ Nicole Valdivieso, as Attorney-in-Fact for Gary M. Winer
Signature date: 20 May 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

HCWB transaction

Common Stock

Purchase

Transaction value: $9,998
Shares: +1,342
Change %: +49%
Price: $7.45
Shares after: 4,075
Date: 16 May 2025
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

These shares were issued pursuant to a conversion of Unsecured Convertible Promissory Notes which were issued to six holders through a Company financing of an aggregate principal of $270,000 in one-year Notes. The Notes contained a mandatory conversion provision, which resulted in the Notes converting into shares of common stock at a mandatory conversion price of $7.45 per share as set by the registered offering. The Notes converted after the closing of the Company's registered offering on May 15, 2025. The conversion transaction also included an allocated portion of the 2,174,311 shares of Wugen Inc. common stock held by the Company.